Flexion Therapeutics Inc

+0.15 (+1.61%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)482.67M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$33.34 Million
Adjusted EPS-$0.42
See more estimates
10-Day MA$8.13
50-Day MA$6.22
200-Day MA$8.64
See more pivots

Flexion Therapeutics Inc Stock, NASDAQ:FLXN

10 Mall Road, Suite 301, Burlington, Massachusetts 01803
United States of America
Phone: +1.781.305.7777
Number of Employees: 257


Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.